Masarova, L., Verstovsek, S., Hidalgo-Lopez, J. E., Pemmaraju, N., Bose, P., Estrov, Z., . . . Daver, N. (2018). A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis. Blood.
Dyfyniad Arddull ChicagoMasarova, Lucia, et al. "A Phase 2 Study of Ruxolitinib in Combination With Azacitidine in Patients With Myelofibrosis." Blood 2018.
Dyfyniad MLAMasarova, Lucia, et al. "A Phase 2 Study of Ruxolitinib in Combination With Azacitidine in Patients With Myelofibrosis." Blood 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.